Ceptur Therapeutics is based in Hillsborough, NJ. It has raised $75M in total funding. Latest round: Series A.
Ceptur Therapeutics is based in Hillsborough, NJ. Ceptur Therapeutics has raised $75M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in January 2022. The round record for Ceptur Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include venBio Partners, Qiming Venture Partners USA, Bristol Myers Squibb, Perceptive Xontogeny Venture (PXV) Fund, Janus Henderson Investors, Affinity Asset Advisors and 2 others. 8 distinct backers are named across the disclosed rounds.
We update the Ceptur Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Hillsborough and their backers are listed below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026